Anthera Pharmaceuticals - Delisted Pink Sheet
Anthera Pharmaceuticals is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Anthera Pharmaceuticals was actively traded.
Valuation
Check how we calculate scores
View Anthera Pharmaceuticals Related Equities
Risk & Return | Correlation |
Anthera Pharmaceuticals Corporate Management
May Liu | Principal Accounting Officer, Compliance Officer and Sr. VP of Fin. and Admin. | Profile | |
Bradley Esq | Sec | Profile | |
Paul Adams | VP Compliance | Profile | |
Joshua Caldwell | Chief Officer | Profile | |
MBA MBA | Ex Chairman | Profile | |
Charles DSc | Advisor | Profile | |
Klara DickinsonEason | Advisor | Profile |
Still Interested in Anthera Pharmaceuticals?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Anthera Pink Sheet
If you are still planning to invest in Anthera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anthera Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |